Kenta Biotech is focusing on the discovery and development of fully human monoclonal antibodies for the life-saving treatment of patients with serious infectious diseases.
Company (Alive / Active)
CH - 3018
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Human monoclonal antibody specific for lipopolysaccharides (lps) of the||Feb 13, 2006||Jun 12, 2012||Patent|
|Human monoclonal antibody specific lipopolysaccharides (lps) of serotype iats 06 of||Nov 10, 2005||Oct 06, 2009||Patent|